Member Info for Parpaing

In 2011 the SP was 21p on less news than this RNS.

Looks even more likely to be setting up a new electricla power plant system for BPL.
See: https://thenassauguardian.com/2019/08/19/chairman-fixing-bpl-will-be-an-economic-game-changer/

More likely to be a US hotel or resort complex, as Minnis spoke about 'construction workers and long term jobs'.

Why are these biom RNSs so negative?
They have good news - increased earnings and sales but always write a really boring and negative RNS. They could be trying to reduce the SP to buy back all the shares at a low cost now that they have positive revenue.

Looking forward to 22 July for the Interim Trading Statement. Should be good.

It's 11k now.

We have made it to second place into the top fallers board. Potter should give us some news.

Yes, I thought that we should have the first bit of news in the middle of September, but not before. That would take Mr Potters's six months into account.

Paul is only interested in the share price for when he retires.

The group’s current obligation – to safely implement an environmentally responsible well prior to the end of 2020.
Not in a rush to drill then.

Not the one we are waiting for and no news either.

According to https://www.barrons.com/quote/stock/uk/xlon/bpc?mod=DNH_S
26% of the stock is owned by institutions. Hopefully, they are more positive than us.

According to: https://www.barrons.com/quote/stock/uk/xlon/trp?mod=DNH_S
42.38% of shares are with institutions. So TRP must be a good bet.

Thanks, PoC. I imagine that we won't hear anything until about September. Seems strange that a deal has not been done by now, considering the willingness of the BG.

This paragraph is in the last RNS.
Potter said that he looks forward to reporting further developments in the coming year. Is the coming year 2020 or the next 12 months?
Going forward, everyone at the Group remains entirely focussed on the singular task of seeing an initial exploration well completed. The Group's current obligation - to safely implement an environmentally responsible well prior to the end of 2020 - has been clearly laid out by the Government in our recent licence extension. The Group has not had the ability to demonstrate this level of certainty of tenure for a considerable period of time. Along with this, we have secured the working capital we need, the Government is supportive, the legislative regime is clear and enacted, and we have an adviser in place. At the same time, the surrounding industry circumstances are favourable, with sustained recovery in the global oil price, and renewed industry interest in frontier exploration. In 2019 and 2020, we thus look forward to delivering: securing the investment needed to drill an initial exploration well and thereby move this exciting project forward.
We would like to thank all our investors and staff for their continued support and perseverance and look forward to reporting on further developments to you over the course of the coming year."

News just issued for XEN.
Entry into CAR T space positions company to drive significant momentum over the course of 2019 advancing XCART platform technology

– XCART initially being developed to target B-cell lymphomas and has the potential to address multiple tumor types with an initial global market opportunity in Non-Hodgkin Lymphoma of over $5 billion annually
“We expect 2019 to be a transformative year for Xenetic. With the anticipated closing of our acquisition
of XCART, our differentiated CAR T platform technology, on track for this quarter, I believe Xenetic will be
well positioned to drive momentum in the innovation and development of new oncology therapeutics
where there remains significant unmet need,” commented Jeffrey Eisenberg, Chief Executive Officer of
Xenetic. “We plan to focus our R&D efforts initially on leveraging the XCART platform to develop cell-
based therapeutics for the treatment of B-cell Non-Hodgkin lymphomas. All of this marks a very important
moment in the evolution of Xenetic, and I firmly believe the Company can become a significant player in
the oncology space with this potentially transformative technology platform, providing therapeutic
solutions for physicians and individuals fighting cancer and their families as well as driving value for our
shareholders.”

No one throws good money away?
That's exactly what I've done on AIM - particularly BPC.

Sorry, I just opened the TRP news as it has a red circle with a 1 on it.

It's in the TRP news on this page. Scroll up.

Wow !
We are number twp on the Top Fallers board.
Plus TRP are placing for funding another drill with Repsol who messed up the last drill which was 'glowing in the dark'. The placing is for 5.9 million.